Results 171 to 180 of about 27,539 (236)

USP30-mediated Deubiquitination of Hexokinase 2 controls the metabolic fate of glucose and tumor progression. [PDF]

Cell Death Dis
Haowei Z, Li X, Liao W, Qin X, Jiang Y, Yang H, Zeng H, Li Y, Xie W, Zhang Y, Xu N.   +10 more
europepmc   +1 more source

Ubiquitin-Specific Protease 10: A New Target in Tumor Immune Escape. [PDF]

Cancer Control
Huang J, Li N, Sun J, Li X.
europepmc   +1 more source

OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer. [PDF]

Cell Death Dis
Ren Y, Zhou F, Tan Z, Yang S, Zhang S, Zhang Y, Fu Y, Zhang M, Liu S.   +8 more
europepmc   +1 more source

A20 regulation of Nuclear Factor-{kappa}B: perspectives for inflammatory lung disease [PDF]

, 2011
Elborn, J. Stuart, Kelly, Catriona, Schock, Bettina C., Shields, Michael D.   +3 more
core   +1 more source

Targeting ubiquitination in disease and therapy. [PDF]

Signal Transduct Target Ther
Yang X, Lan T, Zhang B, Tao X, Qi W, Xie K, Cai Y, Liu C, Han J, Wu H.   +9 more
europepmc   +1 more source

Deubiquitination-related genes define immune subtypes of colorectal cancer and are associated with prognosis and immunotherapy-related signatures. [PDF]

Sci Rep
Xu Y, Mo Z, Jiang Q, Pan J, Xu Q, Jia J.
europepmc   +1 more source

14-3-3ε-dependent deubiquitination and translocation of NLRP3 activates the inflammasome during sepsis. [PDF]

JCI Insight
Li X, Ming S, Cao C, Xu Y, Shu J, Tan N, Huang X, Wu Y.   +7 more
europepmc   +1 more source

ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3. [PDF]

Cell Oncol (Dordr)
Wang Q, Liu X, Yang X, He Z, Chen Y.
europepmc   +1 more source

UBE2M as a bridge spanning neddylation and cell cycle regulation in colorectal adenocarcinoma. [PDF]

Exp Mol Med
Wang Z, Wang Y, Chen Y, Shen H, Lu Y, Tong Y, Xu L, Huang C, Zhang H, Shao Y, Li W, Wang S, Fu Z.   +12 more
europepmc   +1 more source

Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets. [PDF]

PeerJ
Shen X, Wang R, Su F, Guo J, Zhao D, Yuan F, Zhang T, Hou X.   +7 more
europepmc   +1 more source